DK0444482T3 - Oxetanoner - Google Patents

Oxetanoner

Info

Publication number: DK0444482T3
Authority: DK; Denmark
Prior art keywords: oxetanones; novel; formula; image; disclosed
Prior art date: 1990-02-26

Application number

DK91102151.7T

Other languages

Danish (da)

English (en)

Inventor

Andre Dr Szente

Romano Dr Derungs

Hans Peter Dr Maerki

Henri Dr Stalder

Original Assignee

Hoffmann La Roche

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1990-02-26

Filing date

1991-02-15

Publication date

1996-05-06

1991-02-15 Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche

1996-05-06 Application granted granted Critical

1996-05-06 Publication of DK0444482T3 publication Critical patent/DK0444482T3/da

Links

102000019280 Pancreatic lipases Human genes 0.000 abstract 1
108050006759 Pancreatic lipases Proteins 0.000 abstract 1
239000002253 acid Substances 0.000 abstract 1
150000007513 acids Chemical class 0.000 abstract 1
230000002401 inhibitory effect Effects 0.000 abstract 1
229940116369 pancreatic lipase Drugs 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D305/00—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
- C07D305/02—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms not condensed with other rings
- C07D305/10—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms not condensed with other rings having one or more double bonds between ring members or between ring members and non-ring members
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D305/00—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
- C07D305/02—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms not condensed with other rings
- C07D305/10—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms not condensed with other rings having one or more double bonds between ring members or between ring members and non-ring members
- C07D305/12—Beta-lactones

Landscapes

Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
General Health & Medical Sciences (AREA)
Diabetes (AREA)
Hematology (AREA)
Obesity (AREA)
Heart & Thoracic Surgery (AREA)
Urology & Nephrology (AREA)
Vascular Medicine (AREA)
Cardiology (AREA)
Child & Adolescent Psychology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Epoxy Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Plural Heterocyclic Compounds (AREA)
Polyesters Or Polycarbonates (AREA)

DK91102151.7T 1990-02-26 1991-02-15 Oxetanoner DK0444482T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
CH60490		1990-02-26
CH400590		1990-12-17

Publications (1)

Publication Number	Publication Date
DK0444482T3 true DK0444482T3 (da)	1996-05-06

Family

ID=25685091

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK91102151.7T DK0444482T3 (da)	1990-02-26	1991-02-15	Oxetanoner

Country Status (18)

Country	Link
EP (1)	EP0444482B1 (fr)
JP (1)	JP2753403B2 (fr)
KR (1)	KR0183036B1 (fr)
AT (1)	ATE133167T1 (fr)
AU (1)	AU645291B2 (fr)
CA (1)	CA2035967C (fr)
DE (1)	DE59107262D1 (fr)
DK (1)	DK0444482T3 (fr)
ES (1)	ES2082869T3 (fr)
FI (1)	FI115054B (fr)
GR (1)	GR3019618T3 (fr)
HU (1)	HU218272B (fr)
IE (1)	IE72196B1 (fr)
IL (1)	IL97148A (fr)
MC (1)	MC2226A1 (fr)
NO (1)	NO177055C (fr)
NZ (1)	NZ237170A (fr)
PT (1)	PT96887B (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2035972C (fr) *	1990-02-23	2006-07-11	Martin Karpf	Procede de preparation d'oxetanones
CA2098167C (fr) *	1992-06-24	2006-12-19	Dorothea Isler	Aliments pour humains et animaux contenant un inhibiteur de la lipase
NL1004559C2 (nl) *	1996-11-18	1998-05-19	Unilife	Boter.
US6342519B2 (en) *	1999-10-29	2002-01-29	2 Pro Chemical	Oxetanone derivatives
CA2358921A1 (fr) *	1999-10-29	2001-05-10	John Jason Gentry Mullins	Derives d'oxetanone
US6348492B1 (en) *	1999-10-29	2002-02-19	2Pro Chemical	Oxetanone derivatives
DE102004009076A1 (de) *	2004-02-23	2005-10-27	Solvay Pharmaceuticals Gmbh	Alkylcarbamat-substituierte β-Lactone, Verfahren und Zwischenprodukte zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
US7074822B2 (en)	2004-02-23	2006-07-11	Solvay Pharmaceuticals Gmbh	Alkyl carbamate-substituted β-lactones, process for their preparation, and pharmaceutical compositions containing them
EP2212305A4 (fr) *	2007-10-31	2011-10-26	Burnham Inst Medical Research	Composés de bêta-lactone
JP7224331B2 (ja) *	2017-07-12	2023-02-17	メイヨ・ファウンデーション・フォー・メディカル・エデュケーション・アンド・リサーチ	脂肪毒性損傷の低減のための化合物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS608117B2 (ja) *	1977-02-08	1985-02-28	財団法人微生物化学研究会	新生理活性物質エステラスチンおよびその製造法
GB2023604B (en) *	1978-05-25	1982-07-28	Microbial Chem Res Found	Physiologically active derivatives of esterastin and production thereof
JPH0669130B2 (ja) *	1984-08-09	1994-08-31	三菱電機株式会社	遅延線

1991
- 1991-02-05 IL IL9714891A patent/IL97148A/en active IP Right Grant
- 1991-02-07 CA CA002035967A patent/CA2035967C/fr not_active Expired - Fee Related
- 1991-02-15 DE DE59107262T patent/DE59107262D1/de not_active Expired - Fee Related
- 1991-02-15 ES ES91102151T patent/ES2082869T3/es not_active Expired - Lifetime
- 1991-02-15 EP EP91102151A patent/EP0444482B1/fr not_active Expired - Lifetime
- 1991-02-15 AT AT91102151T patent/ATE133167T1/de not_active IP Right Cessation
- 1991-02-15 DK DK91102151.7T patent/DK0444482T3/da not_active Application Discontinuation
- 1991-02-20 HU HU61/91A patent/HU218272B/hu not_active IP Right Cessation
- 1991-02-20 AU AU71228/91A patent/AU645291B2/en not_active Ceased
- 1991-02-20 NZ NZ237170A patent/NZ237170A/en unknown
- 1991-02-21 MC MC912172A patent/MC2226A1/fr unknown
- 1991-02-22 JP JP3131730A patent/JP2753403B2/ja not_active Expired - Fee Related
- 1991-02-25 IE IE63191A patent/IE72196B1/en not_active IP Right Cessation
- 1991-02-25 NO NO910729A patent/NO177055C/no unknown
- 1991-02-26 PT PT96887A patent/PT96887B/pt not_active IP Right Cessation
- 1991-02-26 KR KR1019910003075A patent/KR0183036B1/ko not_active Expired - Fee Related
- 1991-02-26 FI FI910925A patent/FI115054B/fi not_active IP Right Cessation
1996
- 1996-04-09 GR GR960401013T patent/GR3019618T3/el unknown

Also Published As

Publication number	Publication date
IE910631A1 (en)	1991-08-28
NO177055B (no)	1995-04-03
CA2035967A1 (fr)	1991-08-27
IL97148A (en)	1996-11-14
FI115054B (fi)	2005-02-28
NO910729L (no)	1991-08-27
ES2082869T3 (es)	1996-04-01
IL97148A0 (en)	1992-05-25
MC2226A1 (fr)	1993-02-02
GR3019618T3 (en)	1996-07-31
CA2035967C (fr)	2001-10-16
PT96887A (pt)	1991-10-31
IE72196B1 (en)	1997-03-26
FI910925L (fi)	1991-08-27
NO177055C (no)	1995-07-12
PT96887B (pt)	1998-09-30
HU218272B (en)	2000-07-28
KR910021391A (ko)	1991-12-20
JP2753403B2 (ja)	1998-05-20
KR0183036B1 (ko)	1999-05-01
DE59107262D1 (de)	1996-02-29
NZ237170A (en)	1993-12-23
AU645291B2 (en)	1994-01-13
ATE133167T1 (de)	1996-02-15
EP0444482A3 (en)	1991-12-04
EP0444482B1 (fr)	1996-01-17
JPH0770099A (ja)	1995-03-14
NO910729D0 (no)	1991-02-25
FI910925A0 (fi)	1991-02-26
AU7122891A (en)	1991-08-29
HUT56557A (en)	1991-09-30
EP0444482A2 (fr)	1991-09-04

Legal Events

Date	Code	Title	Description
1994-11-21	AHB	Application shelved due to non-payment

Publication	Publication Date	Title
NO970092L (no)	1997-01-09	Dihydrobenzofuraner
DE69111752D1 (de)	1995-09-07	Wiederaufschmelzlötofen.
DE69104652D1 (de)	1994-11-24	Wiederaufschmelzlötofen.
DE69521615D1 (de)	2001-08-09	Streptogramine in gereinigter form, ihre herstellung und diese enthaltende pharmazeutische zusammensetzungen
ATE144498T1 (de)	1996-11-15	Herstellung von substituierten piperidinen
DK0444482T3 (da)	1996-05-06	Oxetanoner
DK0696278T3 (da)	1999-04-26	Herbicidtvirkende substituerede 1-phenyl- eller 1-pyridinylbenzotriazoler
DE69106925D1 (de)	1995-03-09	Härtbare fluoreszierende Siloxanzusammensetzungen.
DK0623620T3 (da)	1999-06-07	5-HT3-pyrrolopyrazinderivater
ATE140228T1 (de)	1996-07-15	Hydroxymethyl-indolizidine und -chinolizidine
FI882444A0 (fi)	1988-05-24	Substituerade vinylkefalosporiner, foerfarande foer deras framstaellning och deras anvaendning som laekemedel.
ATE152729T1 (de)	1997-05-15	Verfahren zur herstellung von 3beta- aminocholansäurederivaten
DK0552631T3 (da)	1998-05-11	Alfa-Aryl-alfa-hydroxy-beta-imidazolinyl-propionsyreamider
EP0529444A3 (en)	1994-09-07	2-arylpropenic acids and their utilisation in the preparation of 5-ketoprofen
DE69108099D1 (de)	1995-04-20	Verfahren zur Herstellung von reinem 4,4'-Dihydroxybiphenyl.
ZA937179B (en)	1995-06-28	Tetrahydorindazolone pharmaceutical compositions
DK0502735T3 (da)	1996-04-09	Fremgangsmåde og mellemprodukter til fremstilling af 2,2-dimethyl-2,3-dihydrobenzofuran-7- carboxylsyrer
DE69100847D1 (de)	1994-02-10	Verfahren zur Herstellung von 4,4'-Dihydroxybiphenyl.
ES8605530A1 (es)	1986-03-16	Procedimiento para la obtencion de triazolil-tionofosfatos